EC Number   |
Natural Substrates |
|---|
    5.2.1.2 | 4-maleylacetoacetate |
- |
| 5.2.1.2 | Maleylacetoacetate |
human maleylacetoacetate isomerase deficiency presumably causes tyrosinemia that can be characterized by the absence of succinylacetone |
| 5.2.1.2 | Maleylacetoacetate |
enzyme of the tyrosine-catabolism |
| 5.2.1.2 | Maleylacetoacetate |
enzyme of the phenylacetate pathway |
| 5.2.1.2 | Maleylacetoacetate |
enzymatic isomerization of cis,cis-muconaldehydic acid to trans,trans-muconaldehydic acid followed by the oxidation is suggested to be the path to trans,trans-muconate |
| 5.2.1.2 | Maleylacetoacetate |
one of the enzymes responsible for the oxidative metabolism of aromatic amino acids |
| 5.2.1.2 | more |
enzyme deficiency would presumably cause tyrosinemia that would be characterized by the absence of succinylacetone |
| 5.2.1.2 | more |
key enzyme in the metabolic degradation of phenylalanine and tyrosine |
| 5.2.1.2 | more |
the enzyme plays an important role in the metabolism of tyrosine |
| 5.2.1.2 | more |
GSTzeta/MAAI is induced during the differentiation of 3T3-L1 fibroblasts into adipocytes. This process requires expression of C/EBPalpha as well as PPARgamma |
